These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

871 related items for PubMed ID: 17667812

  • 1. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N.
    Transplantation; 2007 Jul 27; 84(2):207-13. PubMed ID: 17667812
    [Abstract] [Full Text] [Related]

  • 2. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.
    Pharmacology; 2007 Jul 27; 79(3):184-92. PubMed ID: 17356310
    [Abstract] [Full Text] [Related]

  • 3. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
    Shibuki H, Katai N, Kuroiwa S, Kurokawa T, Arai J, Matsumoto K, Nakamura T, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2002 Feb 27; 43(2):528-36. PubMed ID: 11818401
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 27; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar 27; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 6. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X.
    Nephrology (Carlton); 2006 Dec 27; 11(6):516-23. PubMed ID: 17199790
    [Abstract] [Full Text] [Related]

  • 7. Expression of peroxisome proliferator-activated receptor-gamma in renal ischemia-reperfusion injury.
    Matsuyama M, Yoshimura R, Hase T, Uchida J, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Transplant Proc; 2005 May 27; 37(4):1684-5. PubMed ID: 15919430
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY, Cheng T, Zheng MH, Yi CG, Pan H, Li ZJ, Chen XL, Yu Q, Jiang LF, Zhou FY, Li XY, Yang JQ, Chu TG, Gao WY.
    J Plast Reconstr Aesthet Surg; 2010 Jul 27; 63(7):1209-16. PubMed ID: 19617014
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N.
    Eur J Cardiothorac Surg; 2004 Apr 27; 25(4):530-6. PubMed ID: 15037267
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J, Leung JC, Chan LY, Guo H, Lai KN.
    Nephrol Dial Transplant; 2009 Jul 27; 24(7):2067-77. PubMed ID: 19155534
    [Abstract] [Full Text] [Related]

  • 11. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr 27; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation.
    Hisada S, Shimizu K, Shiratori K, Kobayashi M.
    Rocz Akad Med Bialymst; 2005 Apr 27; 50():142-7. PubMed ID: 16358954
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury.
    Choi DE, Jeong JY, Lim BJ, Na KR, Shin YT, Lee KW.
    Transplant Proc; 2009 Nov 27; 41(9):3590-6. PubMed ID: 19917350
    [Abstract] [Full Text] [Related]

  • 14. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY, Yi CG, Li X, Ma B, Li ZJ, Chen XL, Guo SZ, Gao WY.
    Br J Dermatol; 2009 Apr 27; 160(4):762-70. PubMed ID: 19120328
    [Abstract] [Full Text] [Related]

  • 15. Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure.
    Franquesa M, Alperovich G, Herrero-Fresneda I, Lloberas N, Bolaños N, Fillat C, Rama I, Cruzado JM, Grinyó JM, Torras J.
    Gene Ther; 2005 Nov 27; 12(21):1551-8. PubMed ID: 15973441
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL, Gu ZL, Savitz SI, Han F, Fukunaga K, Qin ZH.
    J Neurosci Res; 2008 Apr 27; 86(5):1132-41. PubMed ID: 18074385
    [Abstract] [Full Text] [Related]

  • 17. Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injury.
    Yoshimura R, Matsuyama M, Segawa Y, Tsuchida K, Takemoto Y, Kuratsukuri K, Kawahito Y, Shinka T, Sano H, Nakatani T.
    Transplant Proc; 2004 Sep 27; 36(7):1946-8. PubMed ID: 15518707
    [Abstract] [Full Text] [Related]

  • 18. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
    Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y.
    J Hepatol; 2007 Dec 27; 47(6):784-92. PubMed ID: 17936399
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M, Sivarajah A, Thiemermann C.
    Cardiovasc Res; 2005 Mar 01; 65(4):772-81. PubMed ID: 15721857
    [Abstract] [Full Text] [Related]

  • 20. Altered PPARgamma expression and activation after transient focal ischemia in rats.
    Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust WD, Landreth GE, Sundararajan S.
    Eur J Neurosci; 2006 Sep 01; 24(6):1653-63. PubMed ID: 17004929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.